☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
CNS drug candidate
VistaGen Therapeutics Acquires WW Rights for Pherin's PH94B nasal spray for the Treatment of Social Anxiety Disorder
September 14, 2018
Load more...
Back to Home